Baricitinib CAS:1187594-09-7

Baricitinib  CAS:1187594-09-7
Product Details

Product Information

CAS NO.1187594-09-7 2.png
Product NameBaricitinib
Molecular Weight371.41
Spec / Purity98%min
Supply Capacity
DetailsBaricitinib (INCB28050, LY3009104) is an oral JAK1 and JAK2 inhibitor. Baricitinib is in Phase III development as a potential treatment for rheumatoid arthritis. It is in Phase II development as a potential treatment for psoriasis and diabetic nephropathy. The related compound in JAK inhibitor is Tofacitinib, currently approved for the treatment of rheumatoid arthritis in the United States.

If you are going to consult the information about baricitinib cas:1187594-09-7 from one of the leading Bioactive Molecules manufacturers and suppliers in China, It is always at your service.